Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
tangshen (1 trial)
tangwang (1 trial)
Diabetic Nephropathies (Phase 1)
Kidney Diseases (Phase 1)
Retinal Diseases (Phase 1)
Trials (2 total)
Trial APIs (2 total)